TXG — 10x Genomics, Inc. stock price, charts and financials

QT7010x Genomics, Inc.

10x Genomics, Inc. (NASDAQ: TXG) is a Healthcare company in the Medical - Healthcare Information Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
47.86
+0.85+1.81%
OverviewShort InterestFilings
TXGQT7010x Genomics, Inc.·NASDAQ
47.86+1.81%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jun 24, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20268-KCurrent report
May 27, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 08, 202610-QQuarterly report
May 07, 20268-KCurrent report
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 28, 2026SC 13GBeneficial ownership statement (passive)
Apr 24, 2026DEFA14AAdditional proxy soliciting materials
Apr 24, 2026DEF 14ADefinitive proxy statement
Apr 16, 20264Statement of changes in beneficial ownership
Mar 25, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 25, 20264Statement of changes in beneficial ownership
Mar 24, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 04, 20264Statement of changes in beneficial ownership
Mar 02, 20264Statement of changes in beneficial ownership
#1 / 25 of 344
Page
▼
/ 14